Mettrum Health Corp. (TSXV:MT) announce that the Company has received an amendment to its license to include both the production and sale of medical cannabis and extracts from Health Canada under the Marihuana for Medical Purposes Regulations at its 60,000 square foot production and distribution facility located in Bowmanville, Ontario.
As quoted in the press release:
Under the MMPR, the license was upgraded from production only and provides Mettrum with the ability to produce and sell dried medical cannabis as well as cannabis extracts from the Bowmanville South facility. This provides the company with total licensed production capacity of 3,500 kg and licensed sales capacity of 3,550 kg of dried cannabis and production and sales capacity of 1,906 kg of cannabis extracts. The Bowmanville South facility has total production capacity on a fully built out basis of 8,000 kg of cannabis representing $60 million in sales plus potential extracts.
Mettrum has three fully licensed facilities to produce and sell dried cannabis and cannabis extracts, with a production capacity on a fully built out basis of 12,000 kg per year. As one of Canada’s largest producers and sellers of medical cannabis, Mettrum is exceptionally well-positioned to serve the needs of a growing and regulated market.
Mettrum Health CEO, Michael Haines, stated:
This latest milestone is significant as we can now transition our distribution hub from our original facility at Bennett Road North, to our largest facility down the road. We continue to advance our business plan. These latest amendments will contribute to our continually improving operational efficiency and margins.
The post Mettrum Receives License Amendment for the Sale of Medical Cannabis and Extracts appeared first on Investing News Network.
To continue reading this story, visit our friend’s website (opens in a new window):: Mettrum Receives License Amendment for the Sale of Medical Cannabis and Extracts